TRENTON, NJ (MERCER)–Artist Dean “RAS” Innocence paints the image of Trenton Olympic Gold Medalist, Athing Mu on the wall of Teracycle on New York Avenue. The Jersey Fresh Graffiti Jam will be held there on Saturday 8/28/2021. A parade honoring “Mo” will be held on Sunday 8/29. Details are being worked out as of this post.
ALLENTOWN, NJ (MONMOUTH)–Acclaimed as the premier touring jazz big band in the United States, the US Army Field Band’s Jazz Ambassadors will perform a free concert in Allentown, New Jersey on Sunday, September 26, 2021 beginning at 3 p.m. behind the Allentown United Methodist Church, 23 Church Street, Allentown, NJ. In case of rain, the concert will be held on the same date and time in the Allentown High School Auditorium at 27 High Street, Allentown, NJ 08501.
The band is coming to Allentown at the invitation of The Allentown Village Initiative (TAVI) through its “Allentown Arts” program, a series of performances and exhibits throughout the year designed to highlight the artistry of Allentown and Upper Freehold in the historic setting of the village of Allentown. Allentown Arts is made possible through the generosity of our community as well as a grant from Monmouth Arts, a partner of the New Jersey State Council on the Arts, and the Monmouth County Board of County Commissioners.
Established in 1969, the 19 piece Jazz Ambassadors orchestra has performed in all 50 states and around the globe. From Carnegie Hall to London, and now to Allentown New Jersey, the Jazz Ambassadors have brought America’s original art form – jazz – to audiences of all ages. Please bring a chair and join us for a program of favorites. Make it an afternoon and enjoy a stroll down historic Main Street with its unique shops and restaurants. More information on the band is available at https://www.armyfieldband.com/about/ensembles/jazz-ambassadors .
Visit www.allentownvinj.org for news and information about TAVI’s ongoing community service programs. A volunteer driven, 501(c)(3) organization, TAVI welcomes everyone’s input and participation. The Jazz Ambassadors’ visit to Allentown is a collaborative effort between TAVI and the Allentown United Methodist Church, the Allentown Business Community Association (ABCA) and Bruno’s One Sweet Ride, which hosted its “Artist on the Avenue” concerts throughout the summer. The next “Allentown Arts” program is scheduled for Sunday, November 14, 2021 at 3 p.m. in the sanctuary of Allentown United Methodist Church featuring the talented faculty and students of Allentown’s own Mill Pond Music Academy.
TRENTON, NJ (MERCER)–According to the U.S. Northern Command in a Tweet earlier today they stated that Joint Base MDL-McGuire, Dix and Lakehurst at the request of the U.S. State Department will be providing temporary housing, sustainment, and support for specified Afghan special immigrant visa applicants and their families, and other vulnerable Afghans. The base will provide housing, medical, logistics, and transportation support.
Governor Phil Murphy shared the tweet this morning and also sent a letter to President Joe Biden yesterday to welcome the Afghans to New Jersey.
“We will welcome Afghan refugees with open arms here in New Jersey at Joint Base McGuire-Dix-Lakehurst. Our state has always served as a shining beacon of hope to the world, and we will do everything in our power to help these refugees rebuild their lives.” — Governor Phil Murphy
This morning’s Tweet from U.S. Northern Command:
The @DeptofDefense recently approved a request for assistance from @StateDept to provide temporary housing, sustainment, and support inside the U.S for specified Afghan special immigrant visa applicants and their families, and other vulnerable Afghans, @jointbasemdl, N.J.
TRENTON, NJ (MERCER)–Interim Police Director Steve E. Wilson today announced that the TPD has just completed its 2021 Summer Youth Camp, where dozens of Trenton children had the opportunity to learn about policing techniques and Trenton history while participating in multiple recreation projects and field trips in and around the city.
The annual TPD-led program, which is open for children ages 10 through 15, ran from July 12, 2021 through Aug. 20, 2021. The program is free for all participating children and their families. Topics included 911 training, K-9 operations, crime scene investigation, dusting for latent fingerprints, police photography, traffic enforcement, gang awareness training, and anti-bullying techniques.
Campers also had art classes courtesy of Art and Soul Studio in Ewing, New Jersey and attended several off-site field trips, including the Bright Meadows Farm for horseback riding, Johnson Corner Farms to learn about fresh foods and gather vegetables, and bowling at Morrisville Lanes. The program ended with a celebration at TPD headquarters on Friday, Aug. 20, 2021, where each graduate was presented with a certificate of academy completion.
“With the TPD, it’s about more than just arresting the bad guys,” said Director Steve Wilson. “We love hosting this program and seeing so many kids take advantage of it this year has been terrific to see. We thank our campers for hanging out with us and hope to see their siblings and friends sign up next year!”
Director Wilson offered his thanks to the people and businesses who donated their time and services to the TPD Summer Camp, including the TPD K-9 and Community Relations Units, the Mercer County Sheriff’s Department, the Roberts Family, Italian People’s Bakery, LaValle’s Jumps LLC, and the Splash Twinz for their guest appearance at the graduation ceremony.
MONROE TOWNSHIP, NJ (MIDDLESEX)–Governor Phil Murphy surveyed flood damage caused by Tropical Storm Henri in Monroe Township with Mayor Stephen Dalina and local officials. We’re grateful to our first responders and volunteers assisting with the recovery effort, and we’ll get this cleaned up.
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” said Acting FDA Commissioner Janet Woodcock, M.D. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.”
Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. EUAs can be used by the FDA during public health emergencies to provide access to medical products that may be effective in preventing, diagnosing, or treating a disease, provided that the FDA determines that the known and potential benefits of a product, when used to prevent, diagnose, or treat the disease, outweigh the known and potential risks of the product.
FDA-approved vaccines undergo the agency’s standard process for reviewing the quality, safety and effectiveness of medical products. For all vaccines, the FDA evaluates data and information included in the manufacturer’s submission of a biologics license application (BLA). A BLA is a comprehensive document that is submitted to the agency providing very specific requirements. For Comirnaty, the BLA builds on the extensive data and information previously submitted that supported the EUA, such as preclinical and clinical data and information, as well as details of the manufacturing process, vaccine testing results to ensure vaccine quality, and inspections of the sites where the vaccine is made. The agency conducts its own analyses of the information in the BLA to make sure the vaccine is safe and effective and meets the FDA’s standards for approval.
Comirnaty contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19. The result of a person receiving this vaccine is that their immune system will ultimately react defensively to the virus that causes COVID-19. The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into – nor does it alter – an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart.
“Our scientific and medical experts conducted an incredibly thorough and thoughtful evaluation of this vaccine. We evaluated scientific data and information included in hundreds of thousands of pages, conducted our own analyses of Comirnaty’s safety and effectiveness, and performed a detailed assessment of the manufacturing processes, including inspections of the manufacturing facilities,” said Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research. “We have not lost sight that the COVID-19 public health crisis continues in the U.S. and that the public is counting on safe and effective vaccines. The public and medical community can be confident that although we approved this vaccine expeditiously, it was fully in keeping with our existing high standards for vaccines in the U.S.”
FDA Evaluation of Safety and Effectiveness Data for Approval for 16 Years of Age and Older
The first EUA, issued Dec. 11, for the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older was based on safety and effectiveness data from a randomized, controlled, blinded ongoing clinical trial of thousands of individuals.
To support the FDA’s approval decision today, the FDA reviewed updated data from the clinical trial which supported the EUA and included a longer duration of follow-up in a larger clinical trial population.
Specifically, in the FDA’s review for approval, the agency analyzed effectiveness data from approximately 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection within a week of receiving the second dose. The safety of Comirnaty was evaluated in approximately 22,000 people who received the vaccine and 22,000 people who received a placebo 16 years of age and older.
Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease.
More than half of the clinical trial participants were followed for safety outcomes for at least four months after the second dose. Overall, approximately 12,000 recipients have been followed for at least 6 months.
The most commonly reported side effects by those clinical trial participants who received Comirnaty were pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills, and fever. The vaccine is effective in preventing COVID-19 and potentially serious outcomes including hospitalization and death.
Additionally, the FDA conducted a rigorous evaluation of the post-authorization safety surveillance data pertaining to myocarditis and pericarditis following administration of the Pfizer-BioNTech COVID-19 Vaccine and has determined that the data demonstrate increased risks, particularly within the seven days following the second dose. The observed risk is higher among males under 40 years of age compared to females and older males. The observed risk is highest in males 12 through 17 years of age. Available data from short-term follow-up suggest that most individuals have had resolution of symptoms. However, some individuals required intensive care support. Information is not yet available about potential long-term health outcomes. The Comirnaty Prescribing Information includes a warning about these risks.
Ongoing Safety Monitoring
The FDA and Centers for Disease Control and Prevention have monitoring systems in place to ensure that any safety concerns continue to be identified and evaluated in a timely manner. In addition, the FDA is requiring the company to conduct postmarketing studies to further assess the risks of myocarditis and pericarditis following vaccination with Comirnaty. These studies will include an evaluation of long-term outcomes among individuals who develop myocarditis following vaccination with Comirnaty. In addition, although not FDA requirements, the company has committed to additional post-marketing safety studies, including conducting a pregnancy registry study to evaluate pregnancy and infant outcomes after receipt of Comirnaty during pregnancy.
The FDA granted this application Priority Review. The approval was granted to BioNTech Manufacturing GmbH.
TRENTON, NJ (MERCER)–The Mercer County Homicide Task Force and the Trenton Police Department are investigating a shooting that occurred in Trenton early Monday morning that left one victim dead, Mercer County Prosecutor Angelo J. Onofri reported.
At approximately 3:47 a.m., on August 23, 2021, Trenton police responded to a ShotSpotter activation on Fountain Avenue. Responding officers located a male victim with multiple gunshot wounds. He was transported to the hospital in critical condition and succumbed to his injuries a few hours later. The victim has been identified as 25-year-old Yanquai Edwards of Rancocas, NJ.
The investigation is ongoing, and no arrests have been made. Anyone with information is asked to contact Detective Janaye Jones at the Mercer County Homicide Task Force office, (609) 989-6406. Tips can also be emailed to firstname.lastname@example.org
Names of 2021* homicide victims:
2/18/2021 Jabree Saunders, 26, from shooting on May 14, 2018